跳至主要内容
临床试验/NCT02296385
NCT02296385已完成不适用

Response to PUFA Intervention According to PPAR Genotypes

Société des Produits Nestlé (SPN)0 个研究点目标入组 200 人开始时间: 2012年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
主要终点
Changes in triglyceride levels in plasma

研究概览

简要总结

To assess the bioefficacy of omega-3 fatty acids (provided by intake of fish oil supplements) depending on genotype of relevant factors in lipid metabolism

详细描述

To assess the bioefficacy of omega-3 fatty acids (provided by intake of fish oil supplements) depending on genotype of relevant factors in lipid metabolism.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy adult between 18 and 40 years of age
  • BMI between 18.5 and 30 kg/m2
  • Sedentary to moderate physical activity habits

排除标准

  • Concomitant treatment: Consumption of dietary supplements or any medication that can affect the study outcomes
  • Actively smoking
  • Suspected abuse of alcohol or illicit drugs
  • Significant illness within the two weeks prior to study start or any active systemic infection or medical condition that may require treatment during the study
  • Known or suspected medical condition related to coagulation
  • Subject who cannot be expected to comply with the study procedures
  • Currently participating or having participated in another clinical trial during the last 4 weeks prior to beginning of this study

结局指标

主要结局

Changes in triglyceride levels in plasma

时间窗: Baseline and 6 weeks intervention

次要结局

  • Assess bioefficacy of EPA and DHA supplementation(Baseline and 6 weeks intervention)

研究者

发起方
Société des Produits Nestlé (SPN)
申办方类型
Industry
责任方
Sponsor

相似试验